{"result": "{\n    \"title\": \"Medication Interaction and Administration Community\",\n    \"summary\": \"This community encompasses various medications and their interactions, particularly focusing on the role of Gómez Enterría as a key source of information regarding medication administration and effects. The relationships highlight the importance of proper medication intake to minimize gastrointestinal discomfort and ensure effective treatment.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical nature of medication administration and the potential consequences of improper use.\",\n    \"findings\": [\n        {\n            \"summary\": \"Gómez Enterría as a central information source\",\n            \"explanation\": \"Gómez Enterría serves as a pivotal entity in this community, providing extensive information on various medications and their interactions. This includes guidance on how to properly administer medications to minimize side effects and enhance efficacy. The relationships with multiple medications indicate Gómez Enterría's role in educating healthcare providers and patients about the importance of medication adherence and the potential consequences of neglecting proper administration. [Data: Entities (3482); Relationships (1612, 3192, 4970, 5352, 5374, +more)]\"\n        },\n        {\n            \"summary\": \"Domperidona's role in enteral nutrition\",\n            \"explanation\": \"Domperidona is highlighted as a medication that promotes gastric emptying, particularly in patients receiving enteral nutrition. Its relationship with enteral nutrition underscores its significance in managing patients who may have difficulty with gastric motility. The proper use of Domperidona can significantly impact patient outcomes, making it a critical component of treatment protocols in specific medical settings. [Data: Entities (3494); Relationships (165)]\"\n        },\n        {\n            \"summary\": \"Ciclofosfamida's side effects and management\",\n            \"explanation\": \"Ciclofosfamida is a chemotherapy agent known for its potential to induce mucositis, particularly in patients undergoing hematopoietic cell transplantation. This highlights the importance of monitoring and managing side effects associated with its use. The relationship with Gómez Enterría indicates that there is a need for comprehensive guidelines on managing these side effects to improve patient care and outcomes. [Data: Entities (2953); Relationships (4518)]\"\n        },\n        {\n            \"summary\": \"Eritromicina's application in digestive procedures\",\n            \"explanation\": \"Eritromicina is utilized to facilitate the passage of a nasoenteral tube through the digestive system, showcasing its practical application in clinical settings. This relationship emphasizes the importance of understanding medication roles in procedural contexts, which can enhance patient comfort and procedural success. The guidance provided by Gómez Enterría regarding its use is crucial for healthcare professionals. [Data: Entities (3510); Relationships (5377)]\"\n        },\n        {\n            \"summary\": \"Diverse medication administration guidelines\",\n            \"explanation\": \"The community includes a variety of medications, each with specific administration guidelines to minimize gastrointestinal discomfort. This diversity highlights the complexity of medication management and the necessity for healthcare providers to be well-informed about the unique requirements of each medication. Gómez Enterría's extensive references to these guidelines serve as a vital resource for ensuring safe and effective medication use. [Data: Entities (3484, 3486, 3487, 3491, 3504, +more); Relationships (5341, 5346, 5351, 5355, 5362, +more)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n3494,DOMPERIDONA,\"Domperidona is a medication that acts as a procinético, promoting gastric emptying and stimulating intestinal motility. It is recommended that Domperidona be taken with meals to decrease gastrointestinal discomfort.\",2\r\n3482,GÓMEZ ENTERRÍA,Gómez Enterría is referenced as a source for information regarding the effects of certain medications and their interactions.,44\r\n2953,CICLOFOSFAMIDA,\"Ciclofosfamida is a chemotherapy agent that is commonly used in the conditioning regimen prior to hematopoietic cell transplantation. It is important for patients to take ciclofosfamida with meals to help reduce gastrointestinal discomfort, which may include symptoms such as nausea and vomiting.\",2\r\n3510,ERITROMICINA,\"Eritromicina is a medication that serves as an antibiotic and is utilized for various medical purposes, including facilitating the passage of a tube through the digestive system. It is recommended that Eritromicina be taken with meals to minimize gastrointestinal discomfort.\",2\r\n3483,ACETAZOLAMIDA,Acetazolamida is a medication that should be taken on an empty stomach to increase absorption.,1\r\n3488,ACICLOVIR,Aciclovir is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3486,ALMAGATO,Almagato is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3493,ALOPURINOL,Alopurinol is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3487,AMINOFILINA,Aminofilina is a medication that should be taken on an empty stomach to increase absorption.,1\r\n3497,AMIODARONA,Amiodarona is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3500,AMITRIPTILINA,Amitriptilina is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3491,ATENOLOL,Atenolol is a medication that should be taken on an empty stomach to increase absorption.,1\r\n3504,AZATIAPRINA,Azatiaprina is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3484,BEZAFIBRATO,Bezafibrato is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3507,BROMOCRIPTINA,Bromocriptina is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3495,CAPTOPRIL,Captopril is a medication that should be taken on an empty stomach to increase absorption.,1\r\n3478,CARBAMAZEPINA,\"Carbamazepina, also known as carbamazepine, is a medication primarily used as an anticonvulsant. It is recommended that this medication be taken with meals to minimize gastrointestinal discomfort. Additionally, the metabolism of carbamazepina can be influenced by alcohol consumption, which may affect its efficacy and safety.\",1\r\n3492,CARBOCISTEÍNA,Carbocisteína is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3498,CEFACLOR,Cefaclor is a medication that should be taken on an empty stomach to increase absorption.,1\r\n3496,CEFUROXIMA,Cefuroxima is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3499,CIPROTERONA,Ciproterona is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3501,CLINDAMICINA,Clindamicina is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3502,CLOXACILINA,Cloxacilina is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3503,COLISTIRAMINA,Colistiramina is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3505,COTRIMOXAZOL,Cotrimoxazol is a medication that should be taken on an empty stomach to increase absorption.,1\r\n3506,DIAZEPAM,Diazepam is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3509,DILTIAZEM,Diltiazem is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3508,DIPIRIDAMOL,Dipiridamol is a medication that should be taken on an empty stomach to increase absorption.,1\r\n3511,DOXICICLINA,Doxiciclina is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3514,ESPIROLACTONA,Espirolactona is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3512,FLUCONAZOL,Fluconazol is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3513,FÓLICO,Fólico is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3485,ÁCIDO ACETILSALICÍLICO,Ácido acetilsalicílico is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3490,MALGADRATO,Malgadrato is a medication that should be taken with meals to decrease gastrointestinal discomfort.,1\r\n3521,INGESTA DE NUTRIENTES,\"Ingesta de nutrientes refers to the consumption of nutrients that can be altered by medications, affecting appetite and gastrointestinal function.\",1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n165,NUTRICIÓN ENTERAL,DOMPERIDONA,Domperidona is used to promote gastric emptying in patients receiving enteral nutrition,218\r\n1612,CALCIO,GÓMEZ ENTERRÍA,Gómez Enterría provides information about the use of Calcio in relation to medication administration,73\r\n3192,MAGNESIO,GÓMEZ ENTERRÍA,Gómez Enterría provides information about the use of Magnesio in relation to medication administration,69\r\n5375,GÓMEZ ENTERRÍA,TABLA 4,Gómez Enterría references Tabla 4 for guidelines on medication administration,57\r\n5331,FUROSEMIDA,GÓMEZ ENTERRÍA,Gómez Enterría provides information about the use of Furosemida in relation to medication administration,49\r\n5347,GÓMEZ ENTERRÍA,METOCLOPRAMIDA,Gómez Enterría provides information about the use of Metoclopramida in relation to medication administration,47\r\n1688,DEXAMETASONA,GÓMEZ ENTERRÍA,Gómez Enterría provides information about the use of Dexametasona in relation to medication administration,47\r\n5330,CIPROFLOXACINO,GÓMEZ ENTERRÍA,Gómez Enterría provides information about the use of Ciprofloxacino in relation to medication administration,47\r\n4970,CICLOFOSFAMIDA,GÓMEZ ENTERRÍA,Gómez Enterría provides information about the use of Ciclofosfamida in relation to medication administration,46\r\n5352,GÓMEZ ENTERRÍA,DOMPERIDONA,Gómez Enterría provides information about the use of Domperidona in relation to medication administration,46\r\n5368,GÓMEZ ENTERRÍA,ERITROMICINA,Gómez Enterría provides information about the use of Eritromicina in relation to medication administration,46\r\n5373,GÓMEZ ENTERRÍA,INTERACCIONES MEDICAMENTO-NUTRIENTE,Gómez Enterría discusses the concept of interacciones medicamento-nutriente in relation to medication effects on nutrition,46\r\n5308,AMOXICILINA,GÓMEZ ENTERRÍA,Gómez Enterría provides information about the use of Amoxicilina in relation to medication administration,46\r\n5339,CISAPRIDA,GÓMEZ ENTERRÍA,Gómez Enterría provides information about the use of Cisaprida in relation to medication administration,46\r\n5341,GÓMEZ ENTERRÍA,ACETAZOLAMIDA,Gómez Enterría provides information about the use of Acetazolamida in relation to medication administration,45\r\n5346,GÓMEZ ENTERRÍA,ACICLOVIR,Gómez Enterría provides information about the use of Aciclovir in relation to medication administration,45\r\n5344,GÓMEZ ENTERRÍA,ALMAGATO,Gómez Enterría provides information about the use of Almagato in relation to medication administration,45\r\n5351,GÓMEZ ENTERRÍA,ALOPURINOL,Gómez Enterría provides information about the use of Alopurinol in relation to medication administration,45\r\n5345,GÓMEZ ENTERRÍA,AMINOFILINA,Gómez Enterría provides information about the use of Aminofilina in relation to medication administration,45\r\n5355,GÓMEZ ENTERRÍA,AMIODARONA,Gómez Enterría provides information about the use of Amiodarona in relation to medication administration,45\r\n5358,GÓMEZ ENTERRÍA,AMITRIPTILINA,Gómez Enterría provides information about the use of Amitriptilina in relation to medication administration,45\r\n5349,GÓMEZ ENTERRÍA,ATENOLOL,Gómez Enterría provides information about the use of Atenolol in relation to medication administration,45\r\n5362,GÓMEZ ENTERRÍA,AZATIAPRINA,Gómez Enterría provides information about the use of Azatiaprina in relation to medication administration,45\r\n5342,GÓMEZ ENTERRÍA,BEZAFIBRATO,Gómez Enterría provides information about the use of Bezafibrato in relation to medication administration,45\r\n5365,GÓMEZ ENTERRÍA,BROMOCRIPTINA,Gómez Enterría provides information about the use of Bromocriptina in relation to medication administration,45\r\n5353,GÓMEZ ENTERRÍA,CAPTOPRIL,Gómez Enterría provides information about the use of Captopril in relation to medication administration,45\r\n5340,CARBAMAZEPINA,GÓMEZ ENTERRÍA,Gómez Enterría provides information about the use of Carbamazepina in relation to medication administration,45\r\n5350,GÓMEZ ENTERRÍA,CARBOCISTEÍNA,Gómez Enterría provides information about the use of Carbocisteína in relation to medication administration,45\r\n5356,GÓMEZ ENTERRÍA,CEFACLOR,Gómez Enterría provides information about the use of Cefaclora in relation to medication administration,45\r\n5354,GÓMEZ ENTERRÍA,CEFUROXIMA,Gómez Enterría provides information about the use of Cefuroxima in relation to medication administration,45\r\n5357,GÓMEZ ENTERRÍA,CIPROTERONA,Gómez Enterría provides information about the use of Ciproterona in relation to medication administration,45\r\n5359,GÓMEZ ENTERRÍA,CLINDAMICINA,Gómez Enterría provides information about the use of Clindamicina in relation to medication administration,45\r\n5360,GÓMEZ ENTERRÍA,CLOXACILINA,Gómez Enterría provides information about the use of Cloxacilina in relation to medication administration,45\r\n5361,GÓMEZ ENTERRÍA,COLISTIRAMINA,Gómez Enterría provides information about the use of Colistiramina in relation to medication administration,45\r\n5363,GÓMEZ ENTERRÍA,COTRIMOXAZOL,Gómez Enterría provides information about the use of Cotrimoxazol in relation to medication administration,45\r\n5364,GÓMEZ ENTERRÍA,DIAZEPAM,Gómez Enterría provides information about the use of Diazepam in relation to medication administration,45\r\n5367,GÓMEZ ENTERRÍA,DILTIAZEM,Gómez Enterría provides information about the use of Diltiazem in relation to medication administration,45\r\n5366,GÓMEZ ENTERRÍA,DIPIRIDAMOL,Gómez Enterría provides information about the use of Dipiridamol in relation to medication administration,45\r\n5369,GÓMEZ ENTERRÍA,DOXICICLINA,Gómez Enterría provides information about the use of Doxiciclina in relation to medication administration,45\r\n5372,GÓMEZ ENTERRÍA,ESPIROLACTONA,Gómez Enterría provides information about the use of Espirolactona in relation to medication administration,45\r\n5370,GÓMEZ ENTERRÍA,FLUCONAZOL,Gómez Enterría provides information about the use of Fluconazol in relation to medication administration,45\r\n5371,GÓMEZ ENTERRÍA,FÓLICO,Gómez Enterría provides information about the use of Fólico in relation to medication administration,45\r\n5343,GÓMEZ ENTERRÍA,ÁCIDO ACETILSALICÍLICO,Gómez Enterría provides information about the use of Ácido acetilsalicílico in relation to medication administration,45\r\n5348,GÓMEZ ENTERRÍA,MALGADRATO,Gómez Enterría provides information about the use of Malgadrato in relation to medication administration,45\r\n5374,GÓMEZ ENTERRÍA,INGESTA DE NUTRIENTES,Gómez Enterría explains how medications can alter the ingesta de nutrientes,45\r\n4518,MUCOSITIS,CICLOFOSFAMIDA,La ciclofosfamida puede inducir mucositis en pacientes sometidos a trasplante de células hematológicas debido a sus efectos secundarios.,19\r\n5377,ERITROMICINA,SONDA NASOENTERAL,La eritromicina se utiliza para ayudar en el paso de la sonda nasoenteral en el sistema digestivo.,17\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}